Literature DB >> 29576410

The effects of early trauma and the FKBP5 gene on PTSD and the HPA axis in a clinical sample of Gulf War veterans.

Dmitri A Young1, Sabra S Inslicht2, Thomas J Metzler3, Thomas C Neylan2, Jessica A Ross4.   

Abstract

Previous research indicates that interactions between FKBP5 single nucleotide polymorphisms (SNPs) and child abuse are associated with posttraumatic stress disorder (PTSD) in adulthood. We examined the relationship between the T-allele of the rs1360780 FKBP5 SNP and child abuse on PTSD and the HPA axis in a clinical sample of Gulf War veterans. Genotyping was completed on 266 veterans and 174 veterans additionally participated in a low dose dexamethasone suppression test (DST). The CAPS was used to determine PTSD status and the THQ was used to determine child abuse operationalized as either childhood physical or sexual abuse. Hierarchical regression models were used to assess FKBP5 × child abuse interactions on PTSD, basal cortisol levels, and post DST cortisol levels. The FKBP5 risk allele and child abuse were separately associated with PTSD diagnosis. The risk allele was also associated with significantly lower cortisol levels at baseline. However, no significant FKBP5 × child abuse interaction on PTSD diagnosis, basal cortisol levels, or greater cortisol suppression was observed. Our results suggest that FKBP5 may be a viable biomarker for PTSD. Nonetheless, further work will be required to reconcile our findings with previous reports of an FKBP5 × child abuse interaction on posttraumatic stress response.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cortisol; Dexamethasone suppression test; Gene × environment interactions; Hypothalamic-pituitary-adrenal axis; PTSD; Trauma

Mesh:

Substances:

Year:  2018        PMID: 29576410     DOI: 10.1016/j.psychres.2018.03.037

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans.

Authors:  Sudhiranjan Gupta; Rakeshwar S Guleria; Yvette Z Szabo
Journal:  Psychiatry Res       Date:  2021-10-26       Impact factor: 3.222

2.  Meta-Analysis of Associations Between Hypothalamic-Pituitary-Adrenal Axis Genes and Risk of Posttraumatic Stress Disorder.

Authors:  Christina M Sheerin; Mackenzie J Lind; Kaitlin E Bountress; Marisa E Marraccini; Ananda B Amstadter; Silviu-Alin Bacanu; Nicole R Nugent
Journal:  J Trauma Stress       Date:  2020-03-26

3.  Working memory reflects vulnerability to early life adversity as a risk factor for substance use disorder in the FKBP5 cortisol cochaperone polymorphism, rs9296158.

Authors:  William R Lovallo; Ashley Acheson; Andrew J Cohoon; Kristen H Sorocco; Andrea S Vincent; Colin A Hodgkinson; David Goldman
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

Review 4.  Current and future functional imaging techniques for post-traumatic stress disorder.

Authors:  Alisha Prasad; Ardalan Chaichi; D Parker Kelley; Joseph Francis; Manas Ranjan Gartia
Journal:  RSC Adv       Date:  2019-08-08       Impact factor: 4.036

5.  Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice.

Authors:  Oriana Maria Maurel; Sebastiano Alfio Torrisi; Cristina Barbagallo; Michele Purrello; Salvatore Salomone; Filippo Drago; Marco Ragusa; Gian Marco Leggio
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

6.  Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders.

Authors:  Hiroki Ishiguro; Yasue Horiuchi; Koichi Tabata; Qing-Rong Liu; Tadao Arinami; Emmanuel S Onaivi
Journal:  Molecules       Date:  2018-07-24       Impact factor: 4.411

7.  A randomized controlled trial comparing the clinical efficacy and cost-effectiveness of eye movement desensitization and reprocessing (EMDR) and integrated EMDR-Dialectical Behavioural Therapy (DBT) in the treatment of patients with post-traumatic stress disorder and comorbid (Sub)clinical borderline personality disorder: study design.

Authors:  Aishah Snoek; Aartjan T F Beekman; Jack Dekker; Inga Aarts; Gerard van Grootheest; Matthijs Blankers; Chris Vriend; Odile van den Heuvel; Kathleen Thomaes
Journal:  BMC Psychiatry       Date:  2020-08-06       Impact factor: 3.630

Review 8.  Genes and hormones of the hypothalamic-pituitary-adrenal axis in post-traumatic stress disorder. What is their role in symptom expression and treatment response?

Authors:  Susanne Fischer; Tabea Schumacher; Christine Knaevelsrud; Ulrike Ehlert; Sarah Schumacher
Journal:  J Neural Transm (Vienna)       Date:  2021-04-07       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.